RGX-121 Gene Therapy for the Treatment of Neuronopathic Mucopolysaccharidosis Type II (MPS II): Interim Analysis of Data from the First in Human Study

被引：0
|
作者：
Harmatz, Paul [1 ]
Ficicioglu, Can [2 ]
Giugliani, Roberto [3 ]
Rajan, Deepa [4 ]
Hagood, Joseph [5 ]
Fiscella, Michele [5 ]
Yang, Lin [6 ]
Gilmor, Michelle [5 ]
Cho, Yoonjin [5 ]
Phillips, Dawn [5 ]
Pisani, Laura [5 ]
Falabella, Paulo [5 ]
机构：
[1] UCSF, Benioff Childrens Hosp Oakland, Oakland, CA USA
[2] Childrens Hosp Philadelhia, Philadelphia, PA USA
[3] Hosp Clin Porto Alegre, Porto Alegre, Brazil
[4] Univ Pittsburgh, Pittsburgh, PA USA
[5] REGENXBIO Inc, Rockville, MD USA
[6] REGENXBIO, Rockville, MD USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
807
引用
收藏
页码：398 / 398
页数：1
相关论文
共 50 条
  • [41] Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome Survey
    Burton, Barbara K.
    Guffon, Nathalie
    Roberts, Jane
    van der Ploeg, Ans T.
    Jones, Simon A.
    MOLECULAR GENETICS AND METABOLISM, 2010, 101 (2-3) : 123 - 129
  • [42] A novel preclinical model of mucopolysaccharidosis type II for developing human hematopoietic stem cell gene therapy
    Shimada, Yohta
    Ishii, Natsumi
    Higuchi, Takashi
    Goto, Motohito
    Ohashi, Toya
    Kobayashi, Hiroshi
    GENE THERAPY, 2023, 30 (3-4) : 288 - 296
  • [43] CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)
    Motas, Sandra
    Haurigot, Virginia
    Garcia, Miguel
    Marco, Sara
    Ribera, Albert
    Roca, Carles
    Sanchez, Xavier
    Sanchez, Vctor
    Molas, Maria
    Bertolin, Joan
    Maggioni, Luca
    Leon, Xavier
    Ruberte, Jesus
    Bosch, Fatima
    JCI INSIGHT, 2016, 1 (09):
  • [44] A novel preclinical model of mucopolysaccharidosis type II for developing human hematopoietic stem cell gene therapy
    Yohta Shimada
    Natsumi Ishii
    Takashi Higuchi
    Motohito Goto
    Toya Ohashi
    Hiroshi Kobayashi
    Gene Therapy, 2023, 30 : 288 - 296
  • [45] An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II
    Das, Sabyasachi
    Rruga, Fatlum
    Montepeloso, Annita
    Dimartino, Agnese
    Spadini, Silvia
    Corre, Guillaume
    Patel, Janki
    Cavalca, Eleonora
    Ferro, Francesca
    Gatti, Alessandra
    Milazzo, Rita
    Galy, Anne
    Politi, Letterio S.
    Rizzardi, Gian Paolo
    Vallanti, Giuliana
    Poletti, Valentina
    Bif, Alessandra
    MOLECULAR THERAPY, 2024, 32 (03) : 619 - 636
  • [46] Clinical trial design for HMI-203 investigational gene therapy for mucopolysaccharidosis type II (MPS II) informed by cross-correction potential and KOL input
    Gingras, Jacinthe
    Haroldson, Jeff
    Smith, Laura J.
    Patel, Kruti
    Salstrom, Jen
    Jordan, Julie
    Cohn, Gabriel M.
    Francone, Omar
    Seymour, Albert
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S46 - S46
  • [47] First in-human, intracisternal dosing of RGX-111, an investigational AAV gene therapy, for a 21-month-old child with mucopolysaccharidosis type I (MPS I): 3.5 year follow-up
    Wang, Raymond Y.
    Movsesyan, Nina
    Kan, Shih-hsin
    Beydoun, Tammam
    Taylor, Mery
    Chang, Richard C.
    Phillips, Dawn
    Burke, Jenna
    Gilmor, Michelle
    Cho, Yoonjin
    Falabella, Paulo
    Pisani, Laura
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [48] Central Nervous System-Targeted Gene Therapy for the Treatment of Neurocognitive Deficits in Mucopolysaccharidosis Type II Mice
    Chen, Guoqing
    Zhan, Xia
    Gao, Xiaolan
    Yi, Mengni
    Liang, Huan
    Chen, Yixiong
    Lin, Qing
    Yang, Jun
    Hou, Shule
    Maegawa, Gustavo
    Zhang, Huiwen
    HUMAN GENE THERAPY, 2025,
  • [49] Application of a Novel Murine Model of Mucopolysaccharidosis Type II for Developing Human Hematopoietic Stem Cell Gene Therapy
    Shimada, Yohta
    Ishii, Natsumi
    Higuchi, Takashi
    Goto, Motohito
    Ohashi, Toya
    Kobayashi, Hiroshi
    MOLECULAR THERAPY, 2022, 30 (04) : 114 - 114
  • [50] The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II)
    Sampayo-Cordero, Miguel
    Miguel-Huguet, Bernat
    Malfettone, Andrea
    Perez-Garcia, Jose Manuel
    Llombart-Cussac, Antonio
    Cortes, Javier
    Pardo, Almudena
    Perez-Lopez, Jordi
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (18) : 1 - 16
12345